US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Aeglea BioTherapeutics Inc (AGLE)
Aeglea BioTherapeutics Inc (AGLE) ニュース

AGLE

Aeglea BioTherapeutics (AGLE)

Aeglea BioTherapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AGLE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/30	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/04/26	05 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/04/26	05 : 40	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/04/26	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/04/03	05 : 36	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/04/02	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/04/02	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/04/02	05 : 06	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/03/20	20 : 14	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/03/19	05 : 06	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/03/18	21 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2024/03/15	05 : 12	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/29	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/28	21 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/28	06 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/28	06 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/28	06 : 32	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/28	06 : 27	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/28	06 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/27	22 : 30	PR Newswire (US)	Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/23	10 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/23	07 : 00	PR Newswire (US)	Aeglea BioTherapeutics Announces Grants of Inducement Awards	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/21	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/16	07 : 18	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/16	07 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/15	05 : 13	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/10	06 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/10	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/10	06 : 05	PR Newswire (US)	Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:AGLE	Aeglea BioTherapeutics Inc
2023/11/04	06 : 00	PR Newswire (US)	Aeglea BioTherapeutics Announces Grants of Inducement Awards	NASDAQ:AGLE	Aeglea BioTherapeutics Inc

Showing the most relevant articles for your search:NASDAQ:AGLE

1 2 3 4 5 6 7 8 9 10 次へ >>

Granite Point Mortgage

Invesco Preferred Etf

Carlsberg AS (PK)

Invesco S&P 500 Equal We...

Clarus Therapeutics (CE)

International Capital St...

Credit Agricole COVERED ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約